Literature DB >> 19377054

Cellular phenotypes in human stenotic lesions from haemodialysis vascular access.

Prabir Roy-Chaudhury1, Yang Wang, Mahesh Krishnamoorthy, Jianhua Zhang, Rupak Banerjee, Rino Munda, Sue Heffelfinger, Lois Arend.   

Abstract

BACKGROUND: Haemodialysis vascular access dysfunction (due to venous stenosis and thrombosis) is a leading cause of hospitalization and morbidity. The aim of the current study was to identify the specific cell types present within stenotic tissue samples from patients with AV fistula and graft failure.
METHODS: Discarded tissue segments were collected from the stenotic portions (usually near the graft-vein anastomosis or the AV anastomosis) of 23 dialysis grafts and 20 AV fistulae, and examined for expression of smooth muscle alpha actin, desmin, vimentin and a macrophage marker.
RESULTS: The majority of cells within the venous neointima (both grafts and fistulae) were myofibroblasts, with a smaller number of desmin positive smooth muscle cells. The graft neointima had a similar cellular phenotype, albeit without any desmin positive contractile smooth muscle cells. The majority of cells within the PTFE graft material were macrophages. Analysis of sequential sections revealed the presence of fibroblasts within the venous neointima and intragraft region.
CONCLUSIONS: Our results demonstrate that contractile smooth muscle cells, myofibroblasts, fibroblasts and macrophages all play a role in the pathogenesis of dialysis access dysfunction (grafts and fistulae). Targeting these specific cell types might result in the development of novel therapeutic paradigms for haemodialysis vascular access dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19377054      PMCID: PMC2734173          DOI: 10.1093/ndt/gfn708

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  27 in total

1.  Time course of vascular remodeling, formation of neointima and formation of neoadventitia after angioplasty in a porcine model.

Authors:  M Maeng; P G Olesen; N C Emmertsen; M Thorwest; T T Nielsen; B O Kristensen; E Falk; H R Andersen
Journal:  Coron Artery Dis       Date:  2001-06       Impact factor: 1.439

2.  Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access.

Authors:  M F Weiss; V Scivittaro; J M Anderson
Journal:  Am J Kidney Dis       Date:  2001-05       Impact factor: 8.860

3.  Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas.

Authors:  Sylvia Stracke; Klaus Konner; Isabella Köstlin; Reinhard Friedl; Peter M Jehle; Vinzenz Hombach; Frieder Keller; Johannes Waltenberger
Journal:  Kidney Int       Date:  2002-03       Impact factor: 10.612

4.  [Circulating recipient cells contribute to graft coronary arteriosclerosis].

Authors:  Masataka Sata; Yasunobu Hirata; Ryozo Nagai
Journal:  J Cardiol       Date:  2002-01       Impact factor: 3.159

Review 5.  Regulation of smooth muscle cell growth in injured artery.

Authors:  A W Clowes; M M Clowes; J Fingerle; M A Reidy
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

6.  Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow.

Authors:  M Kalra; V M Miller
Journal:  J Vasc Res       Date:  2000 Nov-Dec       Impact factor: 1.934

7.  Vascular access blood flow monitoring reduces access morbidity and costs.

Authors:  P McCarley; R L Wingard; Y Shyr; W Pettus; R M Hakim; T A Ikizler
Journal:  Kidney Int       Date:  2001-09       Impact factor: 10.612

8.  Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts.

Authors:  P Roy-Chaudhury; B S Kelly; M A Miller; A Reaves; J Armstrong; N Nanayakkara; S C Heffelfinger
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

9.  Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access.

Authors:  Helen Lee; Braden Manns; Ken Taub; William A Ghali; Stafford Dean; David Johnson; Cam Donaldson
Journal:  Am J Kidney Dis       Date:  2002-09       Impact factor: 8.860

10.  Beta-galactosidase-tagged adventitial myofibroblasts tracked to the neointima in healing rat vein grafts.

Authors:  Jeffrey J Tomas; V Emily Stark; Jimmy L Kim; Randal A Wolff; Debra A Hullett; Thomas F Warner; John R Hoch
Journal:  J Vasc Res       Date:  2003 May-Jun       Impact factor: 1.934

View more
  46 in total

Review 1.  Future research directions to improve fistula maturation and reduce access failure.

Authors:  Haidi Hu; Sandeep Patel; Jesse J Hanisch; Jeans M Santana; Takuya Hashimoto; Hualong Bai; Tambudzai Kudze; Trenton R Foster; Jianming Guo; Bogdan Yatsula; Janice Tsui; Alan Dardik
Journal:  Semin Vasc Surg       Date:  2016-08-26       Impact factor: 1.000

2.  Origin of neointimal cells in arteriovenous fistulae: bone marrow, artery, or the vein itself?

Authors:  Nikolaos Skartsis; Eddie Manning; Yuntao Wei; Omaida C Velazquez; Zhao-Jun Liu; Pascal J Goldschmidt-Clermont; Loay H Salman; Arif Asif; Roberto I Vazquez-Padron
Journal:  Semin Dial       Date:  2011 Mar-Apr       Impact factor: 3.455

Review 3.  Novel paradigms for dialysis vascular access: upstream hemodynamics and vascular remodeling in dialysis access stenosis.

Authors:  Andrea Remuzzi; Bogdan Ene-Iordache
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-29       Impact factor: 8.237

4.  The transcription factor E26 transformation-specific sequence-1 mediates neointima formation in arteriovenous fistula.

Authors:  Wenguang Feng; Phillip Chumley; Michael Allon; James George; David W Scott; Rakesh P Patel; Silvio Litovsky; Edgar A Jaimes
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 5.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

Review 6.  New Insights into Dialysis Vascular Access: Impact of Preexisting Arterial and Venous Pathology on AVF and AVG Outcomes.

Authors:  Roberto I Vazquez-Padron; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

7.  Soluble epoxide hydrolase expression in a porcine model of arteriovenous graft stenosis and anti-inflammatory effects of a soluble epoxide hydrolase inhibitor.

Authors:  William G Sanders; Christophe Morisseau; Bruce D Hammock; Alfred K Cheung; Christi M Terry
Journal:  Am J Physiol Cell Physiol       Date:  2012-05-23       Impact factor: 4.249

8.  A new arteriovenous fistula model to study the development of neointimal hyperplasia.

Authors:  Eddie Manning; Nikolaos Skartsis; Armando M Orta; Omaida C Velazquez; Zhao-Jun Liu; Arif Asif; Loay H Salman; Roberto I Vazquez-Padron
Journal:  J Vasc Res       Date:  2012-01-13       Impact factor: 1.934

Review 9.  Vein graft adaptation and fistula maturation in the arterial environment.

Authors:  Daniel Y Lu; Elizabeth Y Chen; Daniel J Wong; Kota Yamamoto; Clinton D Protack; Willis T Williams; Roland Assi; Michael R Hall; Nirvana Sadaghianloo; Alan Dardik
Journal:  J Surg Res       Date:  2014-01-30       Impact factor: 2.192

Review 10.  Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.

Authors:  Timmy Lee; Prabir Roy-Chaudhury
Journal:  Adv Chronic Kidney Dis       Date:  2009-09       Impact factor: 3.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.